Biogen, Inc. (BIIB)
219.88
-2.94
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
219.10
-0.78
(-0.35%)
After-Hours: 20:00
Biogen Gross Profit Margin (Quarterly) : 61.37% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.37% |
| March 31, 2026 | 63.99% |
| December 31, 2025 | 68.12% |
| September 30, 2025 | 64.29% |
| June 30, 2025 | 68.80% |
| March 31, 2025 | 65.22% |
| December 31, 2024 | 65.46% |
| September 30, 2024 | 65.42% |
| June 30, 2024 | 70.05% |
| March 31, 2024 | 68.65% |
| December 31, 2023 | 67.02% |
| September 30, 2023 | 67.78% |
| June 30, 2023 | 69.80% |
| March 31, 2023 | 66.75% |
| December 31, 2022 | 67.49% |
| September 30, 2022 | 74.26% |
| June 30, 2022 | 74.28% |
| March 31, 2022 | 62.21% |
| December 31, 2021 | 69.49% |
| September 30, 2021 | 75.67% |
| June 30, 2021 | 79.73% |
| March 31, 2021 | 74.94% |
| December 31, 2020 | 35.53% |
| September 30, 2020 | 81.92% |
| June 30, 2020 | 84.60% |
| Date | Value |
|---|---|
| March 31, 2020 | 82.22% |
| December 31, 2019 | 82.80% |
| September 30, 2019 | 84.29% |
| June 30, 2019 | 82.96% |
| March 31, 2019 | 78.24% |
| December 31, 2018 | 82.03% |
| September 30, 2018 | 82.09% |
| June 30, 2018 | 82.39% |
| March 31, 2018 | 80.47% |
| December 31, 2017 | 79.43% |
| September 30, 2017 | 82.72% |
| June 30, 2017 | 82.27% |
| March 31, 2017 | 66.41% |
| December 31, 2016 | 83.58% |
| September 30, 2016 | 80.58% |
| June 30, 2016 | 81.94% |
| March 31, 2016 | 83.30% |
| December 31, 2015 | 84.62% |
| September 30, 2015 | 83.10% |
| June 30, 2015 | 83.03% |
| March 31, 2015 | 81.53% |
| December 31, 2014 | 84.60% |
| September 30, 2014 | 81.73% |
| June 30, 2014 | 80.92% |
| March 31, 2014 | 79.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 96.13% |
| AbbVie, Inc. | 74.71% |
| Gilead Sciences, Inc. | 79.81% |
| Regeneron Pharmaceuticals, Inc. | 83.68% |
| Amgen, Inc. | 72.08% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.56% |
| Return on Assets | 2.81% |
| Return on Invested Capital | 3.30% |
| Profit Margin (Quarterly) | 3.72% |
| Operating Margin (Quarterly) | 16.71% |
| Return on Net Operating Assets | 3.39% |